AIMS: Compared to DSM-IV nicotine dependence, proposed DSM-5 nicotine use disorder (NUD) would lower the threshold from three to two symptoms, and increase the number of criteria used for diagnosis from seven to 11. The impact of the proposed changes on nicotine disorder prevalence and the concurrent validity of diagnostic criteria were examined. DESIGN: Cross-sectional survey to compare DSM-IV and proposed DSM-5 algorithms. SETTING AND PARTICIPANTS: Adolescent (n = 179) and young adult (n = 292) past-year cigarette users recruited from addictions treatment. MEASUREMENTS: Semi-structured clinical interview to evaluate DSM-IV nicotine dependence, and 10 of the 11 proposed DSM-5 NUD criteria; 30-day time-line follow-back; and the Fagerström Test for Nicotine Dependence (FTND). FINDINGS: Prevalence of proposed DSM-5 NUD (two-symptom threshold) was much higher (adolescents: 68.7%, young adults: 86.0%) than DSM-IV nicotine dependence (33.0% and 59.6%, respectively), although prevalence of DSM-5 severe NUD (four-symptom threshold) was similar to DSM-IV nicotine dependence. Concurrent validity analyses in both samples indicated consistent support for DSM-5 severe NUD diagnosis (four symptoms) but not for the moderate NUD (two symptoms) diagnosis, which had modest relations with only FTND score. IRT analyses indicated strong support for the new craving item, but not for the proposed interpersonal problems and hazardous use items. CONCLUSIONS: The proposed DSM-5 nicotine use disorder criteria have substantial limitations when applied to adolescents and young adults, and appear to have low concurrent validity.
AIMS: Compared to DSM-IV nicotine dependence, proposed DSM-5 nicotine use disorder (NUD) would lower the threshold from three to two symptoms, and increase the number of criteria used for diagnosis from seven to 11. The impact of the proposed changes on nicotine disorder prevalence and the concurrent validity of diagnostic criteria were examined. DESIGN: Cross-sectional survey to compare DSM-IV and proposed DSM-5 algorithms. SETTING AND PARTICIPANTS: Adolescent (n = 179) and young adult (n = 292) past-year cigarette users recruited from addictions treatment. MEASUREMENTS: Semi-structured clinical interview to evaluate DSM-IV nicotine dependence, and 10 of the 11 proposed DSM-5 NUD criteria; 30-day time-line follow-back; and the Fagerström Test for Nicotine Dependence (FTND). FINDINGS: Prevalence of proposed DSM-5 NUD (two-symptom threshold) was much higher (adolescents: 68.7%, young adults: 86.0%) than DSM-IV nicotine dependence (33.0% and 59.6%, respectively), although prevalence of DSM-5 severe NUD (four-symptom threshold) was similar to DSM-IV nicotine dependence. Concurrent validity analyses in both samples indicated consistent support for DSM-5 severe NUD diagnosis (four symptoms) but not for the moderate NUD (two symptoms) diagnosis, which had modest relations with only FTND score. IRT analyses indicated strong support for the new craving item, but not for the proposed interpersonal problems and hazardous use items. CONCLUSIONS: The proposed DSM-5 nicotine use disorder criteria have substantial limitations when applied to adolescents and young adults, and appear to have low concurrent validity.
Authors: Christie A Hartman; Heather Gelhorn; Thomas J Crowley; Joseph T Sakai; Michael Stallings; Susan E Young; Soo Hyun Rhee; Robin Corley; John K Hewitt; Christian J Hopfer Journal: J Am Acad Child Adolesc Psychiatry Date: 2008-02 Impact factor: 8.829
Authors: Heather Gelhorn; Christie Hartman; Joseph Sakai; Michael Stallings; Susan Young; Soo Hyun Rhee; Robin Corley; John Hewitt; Christian Hopfer; Thomas Crowley Journal: J Am Acad Child Adolesc Psychiatry Date: 2008-11 Impact factor: 8.829
Authors: David R Strong; Christopher W Kahler; Suzanne M Colby; Pamela C Griesler; Denise Kandel Journal: Drug Alcohol Depend Date: 2008-10-19 Impact factor: 4.492
Authors: Alan J Gelenberg; Michael E Thase; Roger E Meyer; Frederick K Goodwin; Martin M Katz; Helena Chmura Kraemer; William Z Potter; Richard C Shelton; Maurizio Fava; Arif Khan; Madhukar H Trivedi; Philip T Ninan; John J Mann; Susan Bergeson; Jean Endicott; James H Kocsis; Andrew C Leon; Husseini K Manji; Jerrold F Rosenbaum Journal: J Clin Psychiatry Date: 2008-10-07 Impact factor: 4.384
Authors: William S John; Kiran Grover; Lawrence H Greenblatt; Robert P Schwartz; Li-Tzy Wu Journal: J Gen Intern Med Date: 2019-11-08 Impact factor: 5.128
Authors: Sharon M Kelly; Jan Gryczynski; Shannon Gwin Mitchell; Arethusa Kirk; Kevin E O'Grady; Robert P Schwartz Journal: Drug Alcohol Depend Date: 2014-04-13 Impact factor: 4.492
Authors: Deborah S Hasin; Charles P O'Brien; Marc Auriacombe; Guilherme Borges; Kathleen Bucholz; Alan Budney; Wilson M Compton; Thomas Crowley; Walter Ling; Nancy M Petry; Marc Schuckit; Bridget F Grant Journal: Am J Psychiatry Date: 2013-08 Impact factor: 18.112
Authors: Sharon M Kelly; Kevin E O'Grady; Jan Gryczynski; Shannon Gwin Mitchell; Arethusa Kirk; Robert P Schwartz Journal: Subst Abus Date: 2017-07-07 Impact factor: 3.716
Authors: D Shmulewitz; M M Wall; E Aharonovich; B Spivak; A Weizman; A Frisch; B F Grant; D Hasin Journal: Psychol Med Date: 2013-01-14 Impact factor: 7.723